Stay updated with breaking news from Accelerate Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Free Report) in a research note released on Wednesday morning. The firm issued a hold rating on the medical research company’s stock. Accelerate Diagnostics Trading Down 5.2 % NASDAQ:AXDX opened at $1.28 on Wednesday. The stock has a market capitalization of $18.65 million, a price-to-earnings […]
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday. Following the market opening Friday, the Dow traded up 0.18% to 37,536.76 while the NASDAQ rose 0.38% to 15,113.04. The S&P 500 also rose, gaining, 0.19% to 4,790.00.
Accelerate Diagnostics, Inc. (AXDX) Friday announced the pricing of its offering of $15 million of shares and in lieu of common stock to certain investors, pre-funded warrants to purchase shares.
Accelerate Diagnostics, Inc. (AXDX) Friday announced the pricing of its offering of $15 million of shares and in lieu of common stock to certain investors, pre-funded warrants to purchase shares.
TUCSON, Ariz., Jan. 16, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. today announced the launch of a proposed underwritten public offering of 4,500,000 units, each consisting of one share of...